参考文献/References:
[1] LINDENAUER P K, DHARMARAJAN K, QIN Li,et al. Risk trajectories of readmission and death in thefirst year after hospitalization for chronic obstructivepulmonary disease[J]. American Journal of Respiratoryand Critical Care Medicine, 2018, 197(8): 1009-1017.
[2] LEE J, JUNG H M, KIM S K, et al. Factorsassociated with chronic obstructive pulmonary diseaseexacerbation, based on big data analysis[J]. ScientificReports, 2019, 9(1): 6679.
[3] 崔雨佳，刘忠．外周血嗜酸性粒细胞水平与慢性阻塞性肺疾病急性加重期患者临床预后的相关性分析[J]. 现代检验医学杂志 ,2020, 35(3):129-132, 164. CUI Yujia, LIU Zhong. Relationship betweenperipheral blood eosinophil level and the prognosis ofpatients with acute exacerbation of chronic obstructivepulmonary disease[J].Journal of Modern LaboratoryMedicine,2020, 35(3):129-132, 164.
[4] 韩姗姗，赵翠萍 . 重组人脑利钠肽在心力衰竭治疗中的研究进展[J]．临床药物治疗杂志，2019，17（2）：28-31． HAN Shanshan, ZHAO Cuiping. Advances in thetreatment of acute heart failure with recombinanthuman brain natriuretic peptide[J]. Clinical MedicationJournal, 2019, 17(2): 28-31.
[5] 陈丽丽，胡型忠．降钙素原在慢性阻塞性肺疾病合并心力衰竭伴肺部感染中的临床应用 [J]．中国卫生检验杂志 , 2016, 26（12）:1736-1738． CHEN Lili, HU Xingzhong. Clinical application ofPCT in COPD combined with heart exhaustion andlung infection[J]. Chinese Journal of Health LaboratoryTechnology, 2016, 26(12):1736-1738.
[6] RABE K F, HURD S, ANZUETO A, et al. Globalstrategy for the diagnosis, management, and preventionof chronic obstructive pulmonary disease: Goldexecutive summary[J]. American Journal of Respiratoryand Critical Care Medicine, 2007, 176(6): 532-555.
[7] 中华医学会心血管病学分会心力衰竭学组 , 中国医师协会心力衰竭专业委员会 , 中华心血管病杂志编辑委员会 . 中国心力衰竭诊断和治疗指南 2018[J].中华心血管病杂志 ,2018,46 (10): 760-789. Heart Failure Group of Chinese Society of Cardiologyof Chinese Medical Association, Chinese HeartFailure Association of Chinese Medical DoctorAssociation, Editorial Board of Chinese Journal ofCardiology. Chinese guidelines for the diagnosis andtreatment of heart failure 2018 [J]. Chin J Cardiol,2018, 46(10):760-789.
[8] 刘又宁．间隔十年我国慢性阻塞性肺疾病的发病率真的升高了吗 [J]. 中华结核和呼吸杂志 , 2019, 42（2）:81-82. LIU Youning. Has the incidence rate of chronicobstructive pulmonary disease been increased in Chinain ten years[J]. Chinese Journal of Tuberculosis andRespiratory Diseases, 2019, 42(2):81-82.
[9] ZHU Zhaozhong, WANG Xiaofang, Li Xihao, et al.Genetic overlap of chronic obstructive pulmonarydisease and cardiovascular disease-related traits:a large-scale genome-wide cross-trait analysis[J].Respiratory Research, 2019, 20(1): 64.
[10] JAISWAL A, CHICHRA A, NGUYEN V Q, et al.Challenges in the management of patients with chronicobstructive pulmonary disease and heart failure withreduced ejection fraction[J]. Current Heart FailureReports, 2016, 13(1): 30-36.
[11] 张开进．慢性阻塞性肺疾病合并心力衰竭诊治进展[J]. 心血管病学进展 , 2018, 39(3):398-401. ZHANG Kaijin. Advances in diagnosis and therapy ofcoexistent chronic obstructive pulmonary disease andchronic heart failure [J]. Advances in CardiovascularDiseases, 2018, 39(3):398-401.
[12] 刘云．血气分析联合血清 BNP 对慢性阻塞性肺疾病急性加重期合并心力衰竭诊断价值的分析 [J]. 系统医学 , 2017, 2（22）: 46-48. LIU Yun. Analysis of value of blood gas analysiscombined with serum BNP in diagnosis of AECO-PDand heart failure [J]. Systems Medicine, 2017, 2(22):46-48.
[13] 凌玲 , 吕荣 , 汤金梅 , 等 . 中性粒细胞 / 淋巴细胞比值对老年慢性阻塞性肺疾病急性加重期患者并发心力衰竭的预测价值 [J]. 临床内科杂志 , 2019,36(3):196-198. LING Ling, L? Rong, TANG Jinmei, et al. Predictivevalue of neutrophil / lymphocyte ratio in elderlypatients with acute exacerbation of chronic obstructivepulmonary disease complicated with heart failure[J].Journal of Clinical Internal Medicine, 2019, 36(3):196-198.
[14] 胡晓飞，许世佳，孙红，等．三种生物学标志物在心力衰竭患者诊断中的应用 [J]. 中华老年心脑血管病杂志 , 2018, 20(2): 161-163. HU Xiaofei, XU Shijia, SUN Hong. Applicationof three biomarkers in diagnosis of heart failure[J].Chinese Journal of Geriatric Heart Brain and VesselDiseases, 2018, 20(2): 161-163.
[15] 刘凯萌 , 邢利平 , 李彤彤 , 等 . 检测慢性阻塞性肺疾病急性加重期患者血清降钙素原的临床价值 [J]．中国老年学杂志 ,2018, 38(16):3906-3908. LIU Kaimeng, XING Liping, LI Tongtong, et al.Clinical value of serum procalcitonin in patients withacute exacerbation of chronic obstructive pulmonarydisease[J]. Chinese Journal of Gerontology , 2018,38(16):3906-3908.
[16] MAMIC P, HEIDENREICH P A, HEDLIN H,et al. Hospitalized patients with heart failure andcommon bacterial infections: a nationwide analysis ofconcomitant clostridium difficile infection rates and InHospital mortality[J]. Journal of Cardiac Failure, 2016,22(11): 891-900.
[17] 严海忠 , 王伟佳 , 慕月晶 , 等 . 血液及尿液中降钙素原 (PCT) 检测在泌尿系统感染定位中的诊断价值 [J].现代检验医学杂志 , 2017,32(4):116-118. YAN Haizhong, WANG Weijia, MU Yuejing, et al. Diagnostic value of detecting the serum and urine procalcitonin(PCT) for the urinary system infection[J]. Journal of Modern Laboratory Medicine, 2017,32(4):116-118.
[18] 李军民 , 白晓 , 孟茜 , 等 .COPD 患者血清降钙素原水平与肺功能的关系研究 [J]. 现代检验医学杂志 ,2018,33(1):148-150. LI Junmin, BAI Xiao, MENG Xi, et al. Relationshipstudy on serum levels of procalcitonin and pulmonaryfunction in patients with chronic obstructive pulmonarydisease[J]. Journal of Modern Laboratory Medicine,2018,33(1):148-150.
[19] 王翔 , 单洪武 . 慢性阻塞性肺疾病急性加重期 C- 反应蛋白及降钙素原的临床诊断价值 [J]. 中外医学研究 , 2018，16(9):64-65. WANG Xiang, SHAN Hongwu. Clinical diagnosticvalue of C-reactive protein and procalcitonin inacute exacerbation of chronic obstructive pulmonarydisease[J]. Chinese and Foreign Medical Research,2018, 16(9):64-65.
[20] LEE N S, DANIELS L B. Personalized CHF treatment:PCT to guide therapy in heart failure patients[J].International Journal of Cardiology, 2014, 176(2): 307-308.
[21] 季伟星 , 周兴辉 , 王鑫华 , 等 . 血 浆 PCT 水平与AECOPD 合并心力衰竭患者心功能的关系 [J]. 检验医学 , 2016, 31(10):874-877. JI Weixing, ZHOU Xinghui, WANG Xinhua, etal. Relationship between plasma PCT level andcardiac function in AECOPD patients with heartfailure[J]. Laboratory Medicine, 2016, 31(10):874-877.
[22] SEKI N, MATSUMOTO T, FUK AZAWA M.Relationship between the brain natriuretic peptide(BNP) level and prognosis of diabetic nephropathywith microalbuminuria: a 7-Year Follow-Up study[J].Hormone and Metabolic Research, 2018, 50(5): 389-396.
[23] 陈默 , 黄新亮 . 血浆 BNP 在心力衰竭者早期诊断及预后预估中的临床意义 [J]. 中国实验诊断学 , 2018,22(2):221-222. CHEN Mo, HUANG Xingliang. Clinical significance of plasma BNP in early diagnosis and prognosis predictionof patients with heart failure[J]. Chinese Journal ofLaboratory Diagnosis, 2018, 22(2):221-222.
[24] 曾晓铧 , 王静 . 重组人脑钠肽治疗急性心力衰竭的研究进展 [J]. 医学综述 , 2015, 21(1):61-63. ZENG Xiaohua, WANG Jing. Research progressof recombinant human brain natriuretic peptidein the treatment of acute heart failure [J]. MedicalRecapitulate, 2015, 21(1):61-63.
[25] 蔡珠虹 , 赵静 , 刘天佳 , 等．慢性心力衰竭患者 N 端脑钠肽前体 , 脑钠肽与患者心脏超声参数及炎症因子的关系 [J]. 现代生物医学进展 , 2019, 19(8):1459-1462. CAI Zhuhong, ZHAO Jing, LIU Tianjia, et al.Relationship between N terminal pro-brain natriureticpeptide, brain natriuretic peptide, cardiac ultrasoundparameters and inflammatory factors in patientswith chronic heart failure[J]. Progress in ModernBiomedicine, 2019, 19(8):1459-1462.
[26] 郭飞波．CypA，BNP，ET-1 浓度在老年慢性心衰患者中的表达及临床意义 [J]．现代检验医学杂志 ,2016,31(6):88-91. GUO Feibo. Expression characteristics and clinicalsignificance of CypA,BNP and ET-1 in elderly patients with chronic heart failure [J]. Journal of ModernLaboratory Medicine, 2016, 31(6):88-91.
[27] ROBERTS E，LUDMAN AJ ，DWORZYNSKI K, etal. The diagnostic accuracy of the natriuretic peptidesin heart failure: systematic review and diagnostic metaanalysis in the acute care setting[J]. BMJ (ClinicalResearch ed.), 2015, 350(mar04 22):h910.
[28] GARIANI K， DELABAYS A， PERNEGER T V，etal. Use of brain natriuretic peptide to detect previouslyunknown left ventricular dysfunction in patients withacute exacerbation of chronic obstructive pulmonarydisease.[J]. Swiss Medical Weekly, 2011, 141:w13298.
相似文献/References:
[1]周玉宝a,陈芦斌b,刘芳a,等.腹腔镜与ERCP手术后血清CRP和PCT检测比较分析[J].现代检验医学杂志,2015,30(05):4.[doi:10.3969/j.issn.1671-7414.2015.05.002]
ZHOU Yu-baoa,CHEN Lu-binb,LIU Fanga,et al.Comparative Analysis of Serum CRP and PCT
Detection after ERCP and Laparoscopic Operation[J].Journal of Modern Laboratory Medicine,2015,30(03):4.[doi:10.3969/j.issn.1671-7414.2015.05.002]
[2]刘运双.血清降钙素原水平预示革兰阴性菌血症的价值评估[J].现代检验医学杂志,2015,30(02):77.[doi:10.3969/j.issn.1671-7414.2015.02.024]
LIU Yun-shuang.Values of Procalcitonin Level in Serum
for Predicting Gram-negative Bacteremia[J].Journal of Modern Laboratory Medicine,2015,30(03):77.[doi:10.3969/j.issn.1671-7414.2015.02.024]
[3]文 艳,刘爱胜,张 勇,等.ICU危重病患者深部真菌感染血清中降钙素原和（1,3)-β-D葡聚糖联合检测的临床意义[J].现代检验医学杂志,2015,30(02):120.[doi:10.3969/j.issn.1671-7414.2015.02.037]
WEN Yan,LIU Ai-sheng,ZHANG Yong,et al.Diagnosis Value of Joint Detection of Critical Patients Procalcitonin
and(1,3)-beta-D Glucan with Deep Fungus Infection in ICU[J].Journal of Modern Laboratory Medicine,2015,30(03):120.[doi:10.3969/j.issn.1671-7414.2015.02.037]
[4]马志超,黄白丽,阮和球,等.降钙素原联合呼吸道病原体抗体检测在小儿肺炎的诊断价值[J].现代检验医学杂志,2015,30(02):144.[doi:10.3969/j.issn.1671-7414.2015.02.046]
MA Zhi-chao,HUANG Bai-li,RUAN He-qiu,et al.Diagnosis Value of PCT Combined with Respiratory
Pathogen Detection in Pneumonia in Children[J].Journal of Modern Laboratory Medicine,2015,30(03):144.[doi:10.3969/j.issn.1671-7414.2015.02.046]
[5]尹良琼,余艾霞.降钙素原、胱抑素C联合检测对脓毒症患儿28天死亡率的预测价值研究[J].现代检验医学杂志,2017,32(02):153.[doi:10.3969/j.issn.1671-7414.2017.02.043]
YIN Liang-qiong,Y Ai-xia.Predictive Value of the Combined Detection of Procalcitonin
and Cystatin C in Children with Sepsis 28 Days Mortality[J].Journal of Modern Laboratory Medicine,2017,32(03):153.[doi:10.3969/j.issn.1671-7414.2017.02.043]
[6]严海忠,王伟佳,慕月晶,等.血液及尿液中降钙素原(PCT检测在泌尿系统感染定位中的诊断价值[J].现代检验医学杂志,2017,32(04):116.[doi:10.3969/j.issn.1671-7414.2017.04.033]
YAN Hai-zhong,WANG Wei-jia,MU Yue-jing,et al.Diagnostic Value of Detecting the Serum and Urine
Procalcitonin(PCT)for the Urinary System Infection[J].Journal of Modern Laboratory Medicine,2017,32(03):116.[doi:10.3969/j.issn.1671-7414.2017.04.033]
[7]王臣玉,杨丽萍,陈 磊,等.两种降钙素原检测系统比较实验研究[J].现代检验医学杂志,2017,32(04):143.[doi:10.3969/j.issn.1671-7414.2017.04.041]
WANG Chen-yu,YANG Li-ping,CHEN Lei,et al.Methodology Comparison Study
on Two Analysis Systems of Procalcitonin[J].Journal of Modern Laboratory Medicine,2017,32(03):143.[doi:10.3969/j.issn.1671-7414.2017.04.041]
[8]李军民,白 晓,孟 茜,等.COPD患者血清降钙素原水平与肺功能的关系研究[J].现代检验医学杂志,2018,33(01):148.[doi:10.3969/j.issn.1671-7414.2018.01.001]
LI Jun-min,BAI Xiao,MENG Xi,et al.Relationship Study on Serum Levels of Procalcitonin and Pulmonary
Function in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2018,33(03):148.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[9]王亚南.标本溶血对固相免疫层析法检测降钙素原结果影响的实验研究[J].现代检验医学杂志,2018,33(04):127.[doi:10.3969/j.issn.1671-7414.2018.04.035]
WANG Ya-nan.Experimental Study on the Effect of Sample Hemolysis on the Detection
of Procalcitonin by Solid Phase Immunochromatography Assay[J].Journal of Modern Laboratory Medicine,2018,33(03):127.[doi:10.3969/j.issn.1671-7414.2018.04.035]
[10]刘佳丽,王 薇,何法霖,等.全国566家临床实验室血清降钙素原室内质量控制不精密度调查与分析[J].现代检验医学杂志,2018,33(02):139.[doi:10.3969/j.issn.1671-7414.2018.02.001]
LIU Jia-li,WANG Wei,HE Fa-lin,et al.Investigation and Analysis of the Coefficient of Variation of Internal
Quality Control of the Serum Procalcitonin in 566 Laboratories in China[J].Journal of Modern Laboratory Medicine,2018,33(03):139.[doi:10.3969/j.issn.1671-7414.2018.02.001]